nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—ALB—chronic obstructive pulmonary disease	0.534	1	CbGaD
Bismuth Subsalicylate—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.154	0.707	CbGbCtD
Bismuth Subsalicylate—ALB—Prednisone—chronic obstructive pulmonary disease	0.0637	0.293	CbGbCtD
Bismuth Subsalicylate—Epigastric pain—Aminophylline—chronic obstructive pulmonary disease	0.00491	0.036	CcSEcCtD
Bismuth Subsalicylate—Venous thrombosis—Aminophylline—chronic obstructive pulmonary disease	0.0044	0.0322	CcSEcCtD
Bismuth Subsalicylate—PTGS2—leg—chronic obstructive pulmonary disease	0.00437	0.165	CbGeAlD
Bismuth Subsalicylate—TF—respiratory system—chronic obstructive pulmonary disease	0.00383	0.145	CbGeAlD
Bismuth Subsalicylate—Fluid overload—Aminophylline—chronic obstructive pulmonary disease	0.00382	0.028	CcSEcCtD
Bismuth Subsalicylate—Epigastric pain—Salbutamol—chronic obstructive pulmonary disease	0.00353	0.0258	CcSEcCtD
Bismuth Subsalicylate—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00345	0.0253	CcSEcCtD
Bismuth Subsalicylate—TF—connective tissue—chronic obstructive pulmonary disease	0.00337	0.128	CbGeAlD
Bismuth Subsalicylate—TF—bronchus—chronic obstructive pulmonary disease	0.00315	0.119	CbGeAlD
Bismuth Subsalicylate—Fluid overload—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.0201	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Aminophylline—chronic obstructive pulmonary disease	0.00272	0.0199	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Arformoterol—chronic obstructive pulmonary disease	0.00255	0.0187	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Formoterol—chronic obstructive pulmonary disease	0.00255	0.0187	CcSEcCtD
Bismuth Subsalicylate—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00248	0.0182	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Salbutamol—chronic obstructive pulmonary disease	0.00241	0.0177	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00227	0.0166	CcSEcCtD
Bismuth Subsalicylate—TF—Iron uptake and transport—HMOX1—chronic obstructive pulmonary disease	0.00217	0.0255	CbGpPWpGaD
Bismuth Subsalicylate—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00212	0.0156	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00209	0.0245	CbGpPWpGaD
Bismuth Subsalicylate—TF—lung—chronic obstructive pulmonary disease	0.00203	0.0769	CbGeAlD
Bismuth Subsalicylate—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.002	0.0146	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00199	0.0233	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.00181	0.0212	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.00173	0.0202	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00161	0.0189	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00157	0.0115	CcSEcCtD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00154	0.0181	CbGpPWpGaD
Bismuth Subsalicylate—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.0112	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.0112	CcSEcCtD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.00145	0.017	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00133	0.0156	CbGpPWpGaD
Bismuth Subsalicylate—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.00924	CcSEcCtD
Bismuth Subsalicylate—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00884	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00119	0.0139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00118	0.0139	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.00118	0.0139	CbGpPWpGaD
Bismuth Subsalicylate—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00865	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00115	0.0135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.00113	0.043	CbGeAlD
Bismuth Subsalicylate—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.0083	CcSEcCtD
Bismuth Subsalicylate—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00113	0.0083	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00828	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00819	CcSEcCtD
Bismuth Subsalicylate—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00813	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00111	0.013	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00809	CcSEcCtD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.0011	0.0129	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00795	CcSEcCtD
Bismuth Subsalicylate—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.00108	0.0411	CbGeAlD
Bismuth Subsalicylate—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00784	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00766	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00104	0.0122	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00739	CcSEcCtD
Bismuth Subsalicylate—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000999	0.0378	CbGeAlD
Bismuth Subsalicylate—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00099	0.00725	CcSEcCtD
Bismuth Subsalicylate—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000955	0.0361	CbGeAlD
Bismuth Subsalicylate—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000955	0.00699	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000952	0.0112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000941	0.011	CbGpPWpGaD
Bismuth Subsalicylate—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000934	0.00684	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000928	0.0109	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000928	0.0109	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000927	0.0109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000914	0.0346	CbGeAlD
Bismuth Subsalicylate—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.0009	0.00659	CcSEcCtD
Bismuth Subsalicylate—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000893	0.0338	CbGeAlD
Bismuth Subsalicylate—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000889	0.00651	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.000885	0.00648	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000884	0.00648	CcSEcCtD
Bismuth Subsalicylate—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000873	0.0331	CbGeAlD
Bismuth Subsalicylate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000869	0.00636	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000855	0.01	CbGpPWpGaD
Bismuth Subsalicylate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000842	0.00616	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000841	0.00615	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00084	0.00615	CcSEcCtD
Bismuth Subsalicylate—PTGS1—trachea—chronic obstructive pulmonary disease	0.000839	0.0317	CbGeAlD
Bismuth Subsalicylate—TF—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000832	0.00975	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—VEGFA—chronic obstructive pulmonary disease	0.000823	0.00965	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000808	0.00591	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000808	0.00591	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000804	0.00942	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—trachea—chronic obstructive pulmonary disease	0.000802	0.0303	CbGeAlD
Bismuth Subsalicylate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000801	0.00586	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0008	0.00586	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000799	0.00585	CcSEcCtD
Bismuth Subsalicylate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000799	0.00585	CcSEcCtD
Bismuth Subsalicylate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000796	0.00583	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000796	0.00932	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.000794	0.0093	CbGpPWpGaD
Bismuth Subsalicylate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000794	0.00581	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000775	0.00908	CbGpPWpGaD
Bismuth Subsalicylate—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000774	0.00566	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000774	0.00566	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000771	0.00904	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.000766	0.00898	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000758	0.00888	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.000756	0.00886	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—TGFB1—chronic obstructive pulmonary disease	0.000756	0.00886	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000755	0.00552	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000746	0.00546	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000737	0.00863	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000736	0.00539	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000731	0.00535	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000722	0.00846	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000703	0.00515	CcSEcCtD
Bismuth Subsalicylate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000683	0.005	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000679	0.00497	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000673	0.00493	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00067	0.00786	CbGpPWpGaD
Bismuth Subsalicylate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00067	0.0049	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000664	0.00778	CbGpPWpGaD
Bismuth Subsalicylate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00065	0.00476	CcSEcCtD
Bismuth Subsalicylate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00472	CcSEcCtD
Bismuth Subsalicylate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00472	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000643	0.00471	CcSEcCtD
Bismuth Subsalicylate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000641	0.00469	CcSEcCtD
Bismuth Subsalicylate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000641	0.00469	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000639	0.00749	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000638	0.00748	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000635	0.00465	CcSEcCtD
Bismuth Subsalicylate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000632	0.00462	CcSEcCtD
Bismuth Subsalicylate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000627	0.00459	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000623	0.00731	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000615	0.00721	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000612	0.00717	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00446	CcSEcCtD
Bismuth Subsalicylate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000605	0.00443	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000604	0.00707	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—lung—chronic obstructive pulmonary disease	0.000603	0.0228	CbGeAlD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000601	0.00704	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000599	0.00439	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00425	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00058	0.00424	CcSEcCtD
Bismuth Subsalicylate—PTGS2—lung—chronic obstructive pulmonary disease	0.000576	0.0218	CbGeAlD
Bismuth Subsalicylate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000573	0.0042	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.0042	CcSEcCtD
Bismuth Subsalicylate—TF—Differentiation Pathway—IL6—chronic obstructive pulmonary disease	0.000569	0.00667	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00416	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00416	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000565	0.00414	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000564	0.00661	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000561	0.00411	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.0041	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.00409	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000556	0.00407	CcSEcCtD
Bismuth Subsalicylate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000551	0.00404	CcSEcCtD
Bismuth Subsalicylate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000551	0.00404	CcSEcCtD
Bismuth Subsalicylate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000551	0.00404	CcSEcCtD
Bismuth Subsalicylate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000551	0.00404	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000547	0.00641	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00396	CcSEcCtD
Bismuth Subsalicylate—Pain—Montelukast—chronic obstructive pulmonary disease	0.00054	0.00395	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000539	0.00394	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00392	CcSEcCtD
Bismuth Subsalicylate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000534	0.00391	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000534	0.00391	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000531	0.00389	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000531	0.00389	CcSEcCtD
Bismuth Subsalicylate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000531	0.00389	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00387	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000528	0.00387	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000527	0.00618	CbGpPWpGaD
Bismuth Subsalicylate—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000527	0.00386	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000521	0.00611	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00381	CcSEcCtD
Bismuth Subsalicylate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00381	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000518	0.00607	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000514	0.00603	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00375	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00375	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00373	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00373	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.00372	CcSEcCtD
Bismuth Subsalicylate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000504	0.00369	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000503	0.00368	CcSEcCtD
Bismuth Subsalicylate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00368	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.000502	0.00589	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000502	0.00367	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000502	0.00367	CcSEcCtD
Bismuth Subsalicylate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000501	0.00366	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00366	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000495	0.0058	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000484	0.00354	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000483	0.00566	CbGpPWpGaD
Bismuth Subsalicylate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00352	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000479	0.00562	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.000478	0.00561	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000478	0.0056	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00347	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000465	0.00545	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.00334	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000456	0.00334	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00327	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000447	0.00523	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00323	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00323	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000432	0.00316	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00315	CcSEcCtD
Bismuth Subsalicylate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00313	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000427	0.005	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00312	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00312	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.00042	0.00492	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000419	0.0049	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00306	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00305	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000414	0.00486	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000412	0.00483	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000411	0.00482	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.003	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00041	0.003	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.00041	0.0048	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000409	0.00479	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00298	CcSEcCtD
Bismuth Subsalicylate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00298	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000406	0.00297	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000406	0.00297	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000406	0.00297	CcSEcCtD
Bismuth Subsalicylate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00296	CcSEcCtD
Bismuth Subsalicylate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00296	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00295	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00294	CcSEcCtD
Bismuth Subsalicylate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000398	0.00292	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000398	0.00291	CcSEcCtD
Bismuth Subsalicylate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000396	0.0029	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000395	0.00463	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000389	0.00456	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.00283	CcSEcCtD
Bismuth Subsalicylate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00281	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00281	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000383	0.00449	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.0028	CcSEcCtD
Bismuth Subsalicylate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000383	0.0028	CcSEcCtD
Bismuth Subsalicylate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00279	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000381	0.00446	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000379	0.00444	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00275	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000372	0.00436	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000363	0.00425	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00265	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000355	0.0026	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000353	0.00414	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000352	0.00413	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00256	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000339	0.00397	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000338	0.00396	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000335	0.00393	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000334	0.00391	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000332	0.0039	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.00033	0.00387	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000321	0.00376	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000315	0.00369	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00228	CcSEcCtD
Bismuth Subsalicylate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.00219	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000297	0.00349	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000294	0.00345	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000294	0.00345	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00211	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00203	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000275	0.00322	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000272	0.00319	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000271	0.00317	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000269	0.00315	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000267	0.00313	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000262	0.00307	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00186	CcSEcCtD
Bismuth Subsalicylate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00185	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000247	0.0029	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000243	0.00285	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000243	0.00284	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00177	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00024	0.00281	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000235	0.00276	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00169	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00164	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000223	0.00261	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000222	0.0026	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000221	0.00259	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00161	CcSEcCtD
Bismuth Subsalicylate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00161	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00022	0.00258	CbGpPWpGaD
Bismuth Subsalicylate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00161	CcSEcCtD
Bismuth Subsalicylate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.0016	CcSEcCtD
Bismuth Subsalicylate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00159	CcSEcCtD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000217	0.00254	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000216	0.00253	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000216	0.00253	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00153	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000209	0.00245	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000209	0.00245	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000209	0.00245	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000208	0.00243	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00152	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000206	0.00242	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00148	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00147	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000192	0.00225	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000189	0.00222	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000182	0.00213	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000182	0.00213	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.00018	0.00211	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00018	0.0021	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00131	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000175	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000174	0.00203	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00127	CcSEcCtD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000173	0.00203	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000173	0.00202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.00017	0.00199	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000169	0.00198	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000169	0.00198	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000169	0.00198	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00123	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000167	0.00196	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000166	0.00195	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000166	0.00195	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000166	0.00194	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000164	0.00193	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000164	0.00192	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00118	CcSEcCtD
Bismuth Subsalicylate—Rash—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00117	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00117	CcSEcCtD
Bismuth Subsalicylate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00116	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000157	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000156	0.00183	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000154	0.0018	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000152	0.00178	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000151	0.0011	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000146	0.00172	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000145	0.0017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000144	0.00169	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000138	0.00162	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000137	0.00161	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000135	0.00158	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000134	0.00157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000134	0.00157	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000125	0.00147	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000123	0.00144	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000122	0.00144	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000115	0.00135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000115	0.00134	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000111	0.0013	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000109	0.00128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000107	0.00125	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000103	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000101	0.00118	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	9.97e-05	0.00117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	9.97e-05	0.00117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	9.95e-05	0.00117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	9.88e-05	0.00116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.78e-05	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.57e-05	0.00112	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	9.5e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.49e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—chronic obstructive pulmonary disease	9.45e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	9.31e-05	0.00109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	9.28e-05	0.00109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	9.15e-05	0.00107	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	8.79e-05	0.00103	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	8.72e-05	0.00102	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	8.71e-05	0.00102	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.66e-05	0.00101	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	8.29e-05	0.000971	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.18e-05	0.000958	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	8.13e-05	0.000952	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	8.04e-05	0.000942	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	7.92e-05	0.000928	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.9e-05	0.000925	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	7.74e-05	0.000907	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.6e-05	0.00089	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	7.55e-05	0.000885	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.54e-05	0.000883	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	7.39e-05	0.000866	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.9e-05	0.000808	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.87e-05	0.000805	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	6.82e-05	0.000799	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	6.77e-05	0.000794	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.62e-05	0.000775	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	6.43e-05	0.000753	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.39e-05	0.000749	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	6.24e-05	0.000732	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.15e-05	0.00072	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.14e-05	0.00072	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	6.11e-05	0.000716	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.1e-05	0.000714	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GC—chronic obstructive pulmonary disease	5.98e-05	0.000701	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.64e-05	0.000661	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.56e-05	0.000652	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.53e-05	0.000648	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.48e-05	0.000642	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.26e-05	0.000617	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.09e-05	0.000596	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.03e-05	0.000589	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.77e-05	0.000559	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.69e-05	0.000549	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.64e-05	0.000544	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.59e-05	0.000538	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.43e-05	0.000519	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	4.42e-05	0.000518	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	4.36e-05	0.000511	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	4.28e-05	0.000502	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.23e-05	0.000495	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	4.06e-05	0.000476	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	4.05e-05	0.000475	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.04e-05	0.000473	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.99e-05	0.000468	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.94e-05	0.000461	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KL—chronic obstructive pulmonary disease	3.77e-05	0.000442	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.72e-05	0.000436	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.64e-05	0.000427	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.53e-05	0.000413	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.48e-05	0.000407	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.36e-05	0.000393	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.31e-05	0.000388	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.27e-05	0.000383	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.24e-05	0.00038	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	3.23e-05	0.000378	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.16e-05	0.000371	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.07e-05	0.00036	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	2.95e-05	0.000345	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	2.82e-05	0.000331	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.8e-05	0.000328	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.76e-05	0.000323	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.72e-05	0.000318	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.57e-05	0.000301	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.44e-05	0.000286	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	2.35e-05	0.000276	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.28e-05	0.000267	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.26e-05	0.000265	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.23e-05	0.000262	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.09e-05	0.000245	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	2.09e-05	0.000245	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.08e-05	0.000244	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	2e-05	0.000234	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.98e-05	0.000232	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.97e-05	0.000231	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.000222	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.72e-05	0.000202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.66e-05	0.000194	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.59e-05	0.000186	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.25e-05	0.000147	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.23e-05	0.000144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	9.43e-06	0.000111	CbGpPWpGaD
